Continuous Renal Replacement Therapy Market outlook 2025: Four trends fostering global industry growth

Growing cases of diabetes globally is a major factor behind renal failures, which has supported the demand for continuous renal replacement therapies in the last few years. Diabetes damages the blood vessels in the kidney which adversely affects its functioning. Moreover, people suffering from type 2 diabetes are extremely prone to renal diseases. These patients depend on renal replacement procedures.

The rise in the geriatric population primarily in the developed regions like Europe and North America has complemented the need for advanced therapies. The geriatric population is susceptible to various diseases that increase the morbidity rate and make them vulnerable to renal failures and kidney disorders. The prominent aged population suffers from acute kidney failures that supports the need for a reliable CRRT procedure.

Reports estimate that the global continuous renal replacement therapy market size could surpass USD 1.4 billion in terms of total valuation through 2025. Expounded below are some of the main factors likely to impact the industry in the near future.

Adoption of continuous venovenous hemodialysis therapy

Concerning the type of modality, continuous venovenous hemodialysis segment has gained considerable recognition and was responsible for over USD 410 million in revenues during the year 2018. It is regarded as an effective treatment mechanism for patients that suffer from acute renal failure. Moreover, advanced therapies carry technical advantages and are suitable for the geriatric population.

Need for CRRT in non-renal related disorders

In the year 2018, the value of non-renal segment in the continuous renal replacement therapy market stood at USD 180 million and is likely to witness considerable growth in the coming times.  Non-renal diseases like sepsis and inflammatory syndromes may be cured through continuous renal replacement therapies. Moreover, CRRT therapies also play a key role in removing mediators from blood circulation. As a result of which, its increasing use to treat various non-renal disorders will support industry development.  

To access sample pages of this report titled, “Continuous Renal Replacement Therapy Market Size By Modality (Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodiafiltration, Continuous Venovenous Hemodialysis, Slow Continuous Ultrafiltration), By Product (Instruments, Consumables), By Therapy (Renal, Non-renal) Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents, please click on the link below:

https://www.gminsights.com/request-sample/detail/2998

High cases of diabetes in Europe region

Regionally speaking, Europe has emerged as a profitable revenue terrain for continuous renal replacement therapy market. The region witnesses a rising number of baby boomers prone to chronic diseases. Additionally, high cases of diabetes in the U.K. and EU will support the demand for advanced renal replacement therapies.

Corporate strategies of the market players

Continuous renal replacement therapy providers are focusing on improving their offerings to meet the growing health needs of the people in both developed as well as developing nations. The improvement in disposable income among the people has pushed the need for advanced medical treatments that are reliable, safe. up-to-date yet cost-effective.

The leading competitive players in the continuous renal replacement therapy market are entering into mergers, strategic alliances, and acquiring other companies to expand their geographical presence as well as upgrade their technological offerings. For instance, in February 2019, Fresenius Medical Care, the world’s leading provider of dialysis products and services acquired NxStage Medical, Inc. after seeking approval from the antitrust authorities in the U.S.

Other notable companies operating in the market include NikkisoToray, Medical Components, Baxter International, Asahi Kasei Corporation, and Medtronic, to name a few. To sum up, the growing cases of chronic diseases among people young and old in different parts of the world often leading to severe renal disorders will boost the demand for continuous renal replacement therapy.

About Global Market Insights, Inc.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com

Back to news